Literature DB >> 25550056

Diabetes care--improvement through measurement.

Björn Eliasson1, Soffia Gudbjörnsdottir2.   

Abstract

The National Diabetes Register (NDR) of Sweden was initiated in response to The Saint Vincent Declaration (published 1990), to provide a tool for continuous quality assurance in diabetes care. The original purpose, to monitor the results of health centres from year to year and to compare these with national and regional means, is still the most important one, while continuous follow-up of guidelines, treatments and complications are as important on a national level. The data reported contain basal clinical characteristics of the patients, as well as measures of risk-factor control and the presence of diabetes complications. Many clinics use templates within the medical record systems to verify that all information relevant to good quality assurance in diabetes care is complete, and thereafter export data to NDR. In order to create extra value, the NDR web interface, online at ndr.nu, offers functions to use when interacting with the individual patient, such as reports of all information reported to NDR, including medications and risk-factor control. The clinical results are thus reported back to the health centres (printed and instantaneously online), but are also used for scientific analyses. Such are required by the funding bodies to develop the analytical methods by quality registers, and to widely spread information, including publishing in scientific journals. Ongoing studies address, e.g., the effects of different glucose-lowering therapies, the role of ethnicity and migration, patient-reported outcomes and risks of morbidity and mortality in diabetes mellitus.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Epidemiology; Health care; Quality assurance

Mesh:

Year:  2014        PMID: 25550056     DOI: 10.1016/S0168-8227(14)70732-6

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  38 in total

Review 1.  Health-system-based interventions to improve care in pediatric and adolescent type 1 diabetes.

Authors:  Sarah D Corathers; Pamela J Schoettker; Mark A Clements; Betsy A List; Deborah Mullen; Amy Ohmer; Avni Shah; Joyce Lee
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

2.  Risk trajectories of complications in over one thousand newly diagnosed individuals with type 2 diabetes.

Authors:  Gudrun Höskuldsdóttir; Stefan Franzén; Katarina Eeg-Olofsson; Björn Eliasson
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

3.  Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus.

Authors:  A E Berezin; A A Kremzer; T A Samura; T A Berezina; P Kruzliak
Journal:  J Endocrinol Invest       Date:  2015-04-28       Impact factor: 4.256

4.  The development and acceptability of symptom management quality improvement reports based on patient-reported data: an overview of methods used in PROSSES.

Authors:  Alyssa Troeschel; Tenbroeck Smith; Kathleen Castro; Katherine Treiman; Joseph Lipscomb; Ryan M McCabe; Steven Clauser; Eliot L Friedman; Patricia D Hegedus; Kenneth Portier
Journal:  Qual Life Res       Date:  2016-06-23       Impact factor: 4.147

5.  Recent trends in life expectancy for people with type 1 diabetes in Sweden.

Authors:  Dennis Petrie; Tom W C Lung; Aidin Rawshani; Andrew J Palmer; Ann-Marie Svensson; Björn Eliasson; Philip Clarke
Journal:  Diabetologia       Date:  2016-04-05       Impact factor: 10.122

6.  Establishment of the T1D Exchange Quality Improvement Collaborative (T1DX-QI).

Authors:  Guy Todd Alonso; Sarah Corathers; Anvi Shah; Mark Clements; Manmohan Kamboj; Rona Sonabend; Daniel DeSalvo; Sanjeev Mehta; Alyssa Cabrera; Nicole Rioles; Amy Ohmer; Rajiv Mehta; Joyce Lee
Journal:  Clin Diabetes       Date:  2020-04

7.  Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study.

Authors:  Isabelle Steineck; Jan Cederholm; Björn Eliasson; Araz Rawshani; Katarina Eeg-Olofsson; Ann-Marie Svensson; Björn Zethelius; Tarik Avdic; Mona Landin-Olsson; Johan Jendle; Soffia Gudbjörnsdóttir
Journal:  BMJ       Date:  2015-06-22

8.  DPARD: rationale, design and initial results from the Dutch national diabetes registry.

Authors:  Jessica C G Bak; Dick Mul; Erik H Serné; Harold W de Valk; Theo C J Sas; Petronella H Geelhoed-Duijvestijn; Mark H H Kramer; Max Nieuwdorp; Carianne L Verheugt
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

9.  Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes.

Authors:  Christel Hero; Sofia Axia Karlsson; Stefan Franzén; Ann-Marie Svensson; Mervete Miftaraj; Soffia Gudbjörnsdottír; Karolina Andersson-Sundell; Björn Eliasson; Katarina Eeg-Olofsson
Journal:  Diabetes Ther       Date:  2021-07-22       Impact factor: 2.945

10.  Mortality rates and cardiovascular disease burden in type 2 diabetes by occupation, results from all Swedish employees in 2002-2015.

Authors:  Sofia Carlsson; Tomas Andersson; Mats Talbäck; Maria Feychting
Journal:  Cardiovasc Diabetol       Date:  2021-06-26       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.